J L Fox

Author PubWeight™ 133.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Petrosal approach for petroclival meningiomas. Neurosurgery 1988 2.66
2 Anti-siphon and reversible occlusion valves for shunting in hydrocephalus and preventing post-shunt subdural hematomas. J Neurosurg 1973 2.31
3 Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24. J Virol 1985 1.82
4 The microsurgical approach to intracranial aneurysms. Surg Neurol 1975 1.64
5 Structure and organization of the gene encoding human pulmonary surfactant proteolipid SP-B. DNA 1989 1.63
6 Bovine galactosyltransferase: identification of a clone by direct immunological screening of a cDNA expression library. Proc Natl Acad Sci U S A 1986 1.59
7 cDNA and deduced amino acid sequence of human pulmonary surfactant-associated proteolipid SPL(Phe). Proc Natl Acad Sci U S A 1987 1.58
8 Induction of skin carcinogenicity by alcohol and ultraviolet light. Clin Exp Dermatol 2009 1.53
9 The stability of remifentanil hydrochloride and propofol mixtures in polypropylene syringes and polyvinylchloride bags at 22 degrees-24 degrees C. Anesth Analg 2000 1.53
10 Evidence for unpredicted transmembrane domains in acetylcholine receptor subunits. Proc Natl Acad Sci U S A 1985 1.45
11 Negative intracranial pressure hydrocephalus in adults with shunts and its relationship to the production of subdural hematoma. J Neurosurg 1974 1.43
12 Cloning and sequencing of the genes encoding the alpha and beta subunits of C-phycocyanin from the cyanobacterium Agmenellum quadruplicatum. Proc Natl Acad Sci U S A 1984 1.42
13 Anti-GM crop protesters increase activity in the US. Nat Biotechnol 1999 1.38
14 Cystic meningiomas simulating astrocytomas. Report of three cases. J Neurosurg 1974 1.37
15 Myelopathic cervical spondylotic lesions demonstrated by magnetic resonance imaging. J Neurosurg 1988 1.35
16 Location of antigenic determinants on primary sequences of subunits of nicotinic acetylcholine receptor by peptide mapping. Biochemistry 1986 1.18
17 Chemical synthesis of a gene encoding the human complement fragment C5a and its expression in Escherichia coli. Proc Natl Acad Sci U S A 1985 1.17
18 Trauma-induced intention tremor relieved by stereotaxic thalamotomy. Arch Neurol 1966 1.14
19 The role of manipulation following total knee replacement. J Bone Joint Surg Am 1981 1.13
20 Cerebral edema after laser radiation. An electron microscopic study. J Neuropathol Exp Neurol 1966 1.13
21 Optic nerve decompression in osteopetrosis. J Neurosurg 1988 1.11
22 Biophysical and biological activity of a synthetic 8.7-kDa hydrophobic pulmonary surfactant protein SP-B. Proc Natl Acad Sci U S A 1990 1.11
23 Prey size selection and distance estimation in foraging adult dragonflies. J Comp Physiol A Neuroethol Sens Neural Behav Physiol 2005 1.09
24 The spectrum of respiratory disease associated with exposure to metal working fluids. J Occup Environ Med 1998 1.09
25 cDNA, deduced polypeptide structure and chromosomal assignment of human pulmonary surfactant proteolipid, SPL(pVal). J Biol Chem 1988 1.08
26 Cerebrospinal fluid shunts: an experimental evaluation of flow rates and pressure values in the anti-siphon valve. Surg Neurol 1973 1.07
27 The microsurgical approach to acoustic neurinomas. Surg Neurol 1974 1.06
28 Immunochemical tests of acetylcholine receptor subunit models. Nature 1984 1.06
29 Microsurgical removal of suprasellar meningiomas. Neurosurgery 1985 1.06
30 Amino acid sequence of Desulfovibrio vulgaris flavodoxin. J Biol Chem 1977 1.05
31 Cerebrospinal fluid shunts: an experimental comparison of flow rates and pressure values in various commercial systems. J Neurosurg 1972 1.05
32 Relationships among carbonated apatite solubility, crystallite size, and microstrain parameters. Calcif Tissue Int 1999 1.05
33 Superolateral orbital exposure and reconstruction. Surg Neurol 1985 1.05
34 Evidence that the acetylcholine binding site is not formed by the sequence alpha 127-143 of the acetylcholine receptor. Biochemistry 1986 1.05
35 Extensive dural arteriovenous malformation. Case report. J Neurosurg 1986 1.03
36 A combined infratemporal and posterior fossa approach for the removal of giant glomus tumors and chondrosarcomas. Surg Neurol 1987 1.02
37 The effects of laser irradiation on the central nervous system. I. Preliminary studies. J Neuropathol Exp Neurol 1967 1.01
38 An unusual osteolytic lesion of the skull due to a traumatic arachnoid cyst. Neuroradiology 1973 1.01
39 High-level expression of a gene encoding the human complement factor C5a in Escherichia coli. Gene 1986 1.01
40 Effect of cerebrospinal fluid shunts on intracranial pressure and on cerebrospinal fluid dynamics. 2. A new technique of pressure measurements: results and concepts. 3. A concept of hydrocephalus. J Neurol Neurosurg Psychiatry 1973 0.99
41 Lasers and their neurosurgical application. Mil Med 1966 0.99
42 Synthetic peptides used to locate the alpha-bungarotoxin binding site and immunogenic regions on alpha subunits of the nicotinic acetylcholine receptor. Biochemistry 1987 0.99
43 Familial intracranial aneurysms. Six cases among 13 siblings. J Neurosurg 1980 0.99
44 The multiple manifestations of the encephalocraniocutaneous lipomatosis syndrome. Childs Nerv Syst 1987 0.96
45 A novel skeletal drug delivery system for anti-bacterial drugs using self-setting hydroxyapatite cement. Chem Pharm Bull (Tokyo) 1990 0.96
46 Amino acid sequence similarity between spinach chloroplast and mammalian gluconeogenic fructose-1,6-bisphosphatase. Biochem Biophys Res Commun 1985 0.96
47 Self-setting hydroxyapatite cement: a novel skeletal drug-delivery system for antibiotics. J Pharm Sci 1992 0.95
48 Unusual hematomas outside the spinal cord. Report of two cases. J Neurosurg 1973 0.95
49 The effect of ischemia on nerve conduction. Exp Neurol 1967 0.95
50 Glioblastoma multiforme involving the posterior fossa. Case report and review of literature. Dis Nerv Syst 1966 0.95
51 Primary structure of CTP:CMP-3-deoxy-D-manno-octulosonate cytidylyltransferase (CMP-KDO synthetase) from Escherichia coli. J Biol Chem 1986 0.95
52 Removal of algae from Florida lakes by magnetic filtration. Appl Microbiol 1975 0.95
53 Amino acid sequences of Clostridium pasteurianum flavodoxin. Z Naturforsch B 1972 0.94
54 The amino acid sequence of Desulfovibrio vulgaris flavodoxin. Biochem Biophys Res Commun 1973 0.93
55 Gene dosage effect on the expression of the delta-endotoxin genes of Bacillus thuringiensis subsp. kurstaki in Bacillus subtilis and Bacillus megaterium. Gene 1989 0.93
56 Effects of laser irradiation on the central nervous system. II. The intracranial explosion. J Neurol Neurosurg Psychiatry 1968 0.93
57 An unusual atlanto-axial dislocation. Case report. J Neurosurg 1977 0.93
58 Crystals of the trp repressor-operator complex suitable for X-ray diffraction analysis. J Biol Chem 1987 0.92
59 Quantitative microradiography for studying dental enamel demineralization and remineralization. J Pharm Sci 1984 0.90
60 Familial intracranial aneurysms. Case report. J Neurosurg 1982 0.87
61 Crystallization of C-phycocyanin from the marine blue-green alga Agmenellum quadruplicatum. J Mol Biol 1977 0.87
62 Factors affecting survival of children with malignant gliomas. Neurosurgery 1987 0.87
63 Complaints raised over restricted microarray access. Nat Biotechnol 1999 0.87
64 High-level C5a gene expression and recovery of recombinant human C5a from Escherichia coli. Agents Actions 1987 0.86
65 Intermittent drainage of intracranial cyst via the subcutaneous Ommaya reservoir. Technical note. J Neurosurg 1967 0.86
66 Isolation of a soluble factor needed for protein synthesis with various messenger ribonucleic acids other than poly(U). J Biol Chem 1974 0.85
67 Suprasellar arachnoid cysts: an extension of the membrane of Liliequist. Neurosurgery 1980 0.85
68 Purification and characterization of the C-phycocyanin from Agmenellum quadruplicatum. Biochim Biophys Acta 1980 0.85
69 Neurosurgical hyponatremia: the role of inappropriate antidiuresis. J Neurosurg 1971 0.85
70 PET scan controversy aired. Science 1984 0.85
71 Microsurgery for giant craniopharyngiomas in children. Neurosurgery 1985 0.85
72 Identification of radiologic coordinates for the posterior articular nerve of Luschka in the lumbar spine. Surg Neurol 1973 0.85
73 A novel skeletal drug-delivery system using self-setting calcium phosphate cement. 4. Effects of the mixing solution volume on the drug-release rate of heterogeneous aspirin-loaded cement. J Pharm Sci 1994 0.85
74 Primary cranial and intracranial chondrosarcoma. A survey. Acta Neurochir (Wien) 1985 0.84
75 A novel skeletal drug delivery system using self-setting calcium phosphate cement. 7. Effect of biological factors on indomethacin release from the cement loaded on bovine bone. J Pharm Sci 1994 0.84
76 Physical model evaluation of topical prodrug delivery-simultaneous transport and bioconversion of vidarabine-5'-valerate II: Parameter determinations. J Pharm Sci 1979 0.84
77 Gene-therapy death prompts broad civil lawsuit. Nat Biotechnol 2000 0.83
78 Quantitation of cutaneous Langerhans cells of sarcoidosis patients. J Invest Dermatol 1983 0.83
79 Structural localization of the sequence alpha 235-242 of the nicotinic acetylcholine receptor. Biochem Biophys Res Commun 1985 0.83
80 Al-Zahrawi and Arabian neurosurgery, 936-1013 AD. Surg Neurol 1986 0.83
81 Gene therapy safety issues come to fore. Nat Biotechnol 1999 0.83
82 Histidine decarboxylase of Lactobacillus 30a. Comparative sequences of the beta chain from wild type and mutant enzymes. J Biol Chem 1982 0.83
83 Compatibility of ondansetron hydrochloride with fluconazole, ceftazidime, aztreonam, and cefazolin sodium under simulated Y-site conditions. Am J Hosp Pharm 1994 0.83
84 Multiple oncotic intracranial aneurysms and cardiac metastasis from choriocarcinoma: case report and review of the literature. Neurosurgery 1987 0.83
85 Surfactant peptides stimulate uptake of phosphatidylcholine by isolated cells. Biochim Biophys Acta 1989 0.83
86 Chain termination in vitro. Studies on the specificity of amber and ochre triplets. Biochem Biophys Res Commun 1968 0.82
87 Columbia awarded biotechnology patent. Science 1983 0.82
88 Combined effects of laser irradiation/solution fluoride ion on enamel demineralization. J Clin Laser Med Surg 1998 0.81
89 Electronic structures of lumazines and isoalloxazines. Biochim Biophys Acta 1967 0.81
90 Human T-cell leukemia virus type II: primary structure analysis of the major internal protein, p24 and the nucleic acid binding protein, p15. Virology 1985 0.81
91 A novel skeletal drug-delivery system using self-setting calcium phosphate cement. 3. Physicochemical properties and drug-release rate of bovine insulin and bovine albumin. J Pharm Sci 1994 0.81
92 A novel skeletal drug delivery system using self-setting calcium phosphate cement. 2. Physicochemical properties and drug release rate of the cement-containing indomethacin. J Pharm Sci 1994 0.80
93 Physical model for non-steady-state dissolution of dental enamel. J Dent Res 1987 0.80
94 Histiocytosis-X of the spinal cord: a case report. Neurosurgery 1986 0.80
95 Physical model evaluation of topical prodrug delivery-simultaneous transport and bioconversion of vidarabine-5'-valerate I: Physical model development. J Pharm Sci 1979 0.80
96 Lasing characteristics of new coumarin-analog dyes: broadband and narrow-1 inewidth performance. Appl Opt 1988 0.80
97 Quantitative microradiographic study of simultaneous demineralization/remineralization of dental enamel in weak acid buffers. J Pharm Sci 1984 0.80
98 Obliteration of midline vertebral artery aneurysm via basilar craniectomy. J Neurosurg 1967 0.80
99 Stability of ondansetron hydrochloride and 12 medications in plastic syringes. Am J Health Syst Pharm 1998 0.80
100 Sodium dithionite reduction of flavin. FEBS Lett 1974 0.80
101 Agent Orange study is like a chameleon. Science 1984 0.79
102 Researchers discuss NIH's nanotechnology initiative. Nat Biotechnol 2000 0.79
103 Localization of the respiratory motor pathway in the upper cervical spinal cord following percutaneous cordotomy. Neurology 1969 0.79
104 Solution activity product (KFAP) and simultaneous demineralization-remineralization in bovine tooth enamel and hydroxyapatite pellets. J Pharm Sci 1983 0.79
105 The aberrant jugular bulb. Comput Radiol 1986 0.79
106 Stability of ceftazidime (with arginine) stored in plastic syringes at three temperatures. Am J Hosp Pharm 1992 0.78
107 Use of a modified 7H-11 agar to increase growth rate of Mycobacterium bovis from bovine tissues. Aust Vet J 1986 0.78
108 Value of angiography in cerebral nail-gun injuries. AJNR Am J Neuroradiol 1986 0.78
109 Effect of acid type on kinetics and mechanism of dental enamel demineralization. J Dent Res 1987 0.78
110 Cerebral arterial revascularization: the value of repeated angiography in selection of patients for operation. Neurosurgery 1979 0.78
111 The relief of intracranial vasospasm: an experimental study with methylprednisolone and cortisol. Surg Neurol 1975 0.78
112 Percutaneous technique for insertion of an atrial catheter for CSF shunting. Technical note. J Neurosurg 1981 0.78
113 Stability of ceftazidime in plastic syringes and glass vials under various storage conditions. Am J Hosp Pharm 1992 0.78
114 Effect of particle size of metastable calcium phosphates on mechanical strength of a novel self-setting bioactive calcium phosphate cement. J Biomed Mater Res 1995 0.78
115 Compatibility of ceftazidime and aminophylline admixtures for different methods of intravenous infusion. Ann Pharmacother 1992 0.78
116 The use of laser radiation as a surgical "light knife". J Surg Res 1969 0.78
117 Neurogenic bladder and the tethered spinal cord syndrome. J Urol 1979 0.78
118 Electron probe micro-analysis for subsurface demineralization and remineralization of dental enamel. J Dent Res 1989 0.78
119 The Cushing reflex in the absence of intracranial hypertension. Ann Clin Res 1986 0.78
120 Medulloblastomas: a review of modern management with a report on 75 cases. Surg Neurol 1985 0.78
121 Comparison of three lasers on dental pulp chamber temperature change. J Clin Laser Med Surg 1993 0.77
122 Syringomyelia after decompressive laminectomy for cervical spondylosis. Surg Neurol 1987 0.77
123 Embolization of an arteriovenous malformation of the brain stem. Surg Neurol 1977 0.77
124 Metastable equilibrium solubility behavior of bone mineral. Calcif Tissue Int 1999 0.77
125 A novel skeletal drug delivery system using self-setting calcium phosphate cement. 9: Effects of the mixing solution volume on anticancer drug release from homogeneous drug-loaded cement. J Pharm Sci 1995 0.77
126 The anxiolytic serotonin 5-HT1A receptor agonists buspirone, ipsapirone and gepirone are inhibitors of tyrosine hydroxylation in rat striatum. Behav Brain Res 1996 0.77
127 Characterization of the flavoenzyme enoyl reductase of fatty acid synthetase from yeast. Eur J Biochem 1980 0.77
128 Heat-treatment-induced reduction in the apparent solubility of human dental enamel. J Dent Res 1994 0.77
129 Gene splicers contemplate the rat brain. Science 1983 0.77
130 Stability of ceftazidime (with arginine) and of cefuroxime sodium in infusion-pump reservoirs. Am J Hosp Pharm 1992 0.77
131 Stability of ondansetron hydrochloride and dexamethasone sodium phosphate in infusion bags and syringes for 32 days. Am J Health Syst Pharm 1996 0.77
132 Gene-splicing protein to have orphan drug status. Science 1984 0.77
133 Cerebral vasospasm: a clinical observation. Surg Neurol 1978 0.77
134 Dioxins' health effects remain puzzling. In vitro tests suggests it causes cancer, medical results remain ambiguous. Science 1983 0.76
135 A novel skeletal drug delivery system using a self-setting calcium phosphate cement. 5. Drug release behavior from a heterogeneous drug-loaded cement containing an anticancer drug. J Pharm Sci 1994 0.76
136 Orthostatic hypotension following bilateral percutaneous cordotomy. A case report of treatment with anti-G suit. Acta Neurochir (Wien) 1971 0.76
137 Dissolution rate behavior of hydroxyapatite-fluorapatite mixtures. Caries Res 1983 0.76
138 EPA data base in turmoil. Science 1984 0.76
139 Dorsal column stimulation for relief of intractable pain: problems encountered with neuropacemakers. Surg Neurol 1974 0.76
140 Percutaneous ventriculocisternal shunt. Technical note. Surg Neurol 1985 0.76
141 Persistence of primitive cerebral vasculature in a newborn. A case report of whole brain AVM. Clin Neurol Neurosurg 1986 0.75
142 Particle size effect of metastable calcium phosphates on crushing strength of self-setting bioactive calcium phosphate cement. Chem Pharm Bull (Tokyo) 1993 0.75
143 Effect of geometrical cement size on in vitro and in vivo indomethacin release from self-setting apatite cement. J Control Release 1998 0.75
144 Warning headache in aneurysmal subarachnoid hemorrhage. Arch Neurol 1989 0.75
145 Powder suspension method for critically re-examining the two-site model for hydroxyapatite dissolution kinetics. J Pharm Sci 1984 0.75
146 Kinetics and mechanism of hydroxyapatite crystal dissolution in weak acid buffers using the rotating disk method. J Dent Res 1976 0.75
147 Mechanochemical synthesis of bioactive material: effect of environmental conditions on the phase transformation of calcium phosphates during grinding. Biomed Mater Eng 1994 0.75
148 IMpact-RSV Study Group report. Pediatrics 1999 0.75
149 Canadian farmer found guilty of Monsanto canola patent infringement. Nat Biotechnol 2001 0.75
150 Physical model evaluation of topical prodrug delivery--simultaneous transport and bioconversion of vidarabine-5'-valerate IV: Distribution of esterase and deaminase enzymes in hairless mouse skin. J Pharm Sci 1980 0.75
151 Stability of cisatracurium besylate in vials, syringes, and infusion admixtures. Am J Health Syst Pharm 1998 0.75
152 Saving chimps for research. Science 1984 0.75
153 Soil Microbes Pose Problems for Pesticides: Microbes in some soils are undermining the efficacy of pesticides; the problem is only recently discovered and is poorly understood. Science 1983 0.75
154 Will there be life on the farm after the bomb? Science 1983 0.75
155 Injected virus probes fetal development. Science 1984 0.75
156 Naratriptan hydrochloride in extemporaneosly compounded oral suspensions. Int J Pharm Compd 2013 0.75
157 Senate wants Academy to assess medical technology. Science 1984 0.75
158 US food labeling policy softens. Nat Biotechnol 1999 0.75
159 Reduced epidermal Langerhans cell densities in patients with pulmonary malignancies do not correlate with anergy or nutritional status. J Dermatol Surg Oncol 1985 0.75
160 Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions. Am J Hosp Pharm 1993 0.75
161 USDA's food-safety push boosts assay makers. Biotechnology (N Y) 1995 0.75
162 Stability of sumatriptan succinate in extemporaneously prepared oral liquids. Am J Health Syst Pharm 1997 0.75
163 USDA appeases organic lobby. Nat Biotechnol 1999 0.75
164 EPA biotech rule reviewed yet again. Nat Biotechnol 1999 0.75
165 Despite doubts RAC moving to widen role. Science 1984 0.75
166 Puberty due to a mixed germ cell tumour of the hypothalamus secreting BhCG and alpha-fetoprotein. Horm Res 1987 0.75
167 The DNA double helix turns 30. A celebration in Boston brought Watson and Crick together in a rare joint appearance. Science 1983 0.75
168 EPA Dumps Chemical Data System: Ignoring recommendations in two reports, EPA is handing over the system to industry in a move that critics say will lead to chaos. Science 1984 0.75
169 NAS report: strengthen agbio regs and relations. National Academy of Sciences. Nat Biotechnol 2000 0.75
170 Fluoride remineralization of demineralized bovine tooth enamel and hydroxyapatite pellets. J Pharm Sci 1981 0.75
171 Anterior cervical decompression and fusion for cervical spondylosis. Med Ann Dist Columbia 1968 0.75
172 Overview of FY 2000 US federal budget request. Nat Biotechnol 1999 0.75
173 EPA tightens pesticide, toxic chemical testing. Science 1983 0.75
174 Biotech plays big role in efforts against AIDS. Biotechnology (N Y) 1995 0.75
175 Pinning down a moving target: a standard HIV. Biotechnology (N Y) 1995 0.75
176 Separation of amino acid phenylthiohydantoin derivatives by high-pressure liquid chromatography. Anal Biochem 1986 0.75
177 Rhône-Poulenc rounds up DeKalb and Monsanto. Nat Biotechnol 1997 0.75
178 "NIH-money-for-drug-patent-life" proposal rejected. Nat Biotechnol 1997 0.75
179 Bush FY 2002 federal budget request vague. Nat Biotechnol 2001 0.75
180 Results of cervical laminectomy with dural graft for severe spondylosis with narrow canal. Acta Neurol Latinoam 1972 0.75
181 Placing APL on the agenda. Sr Nurse 1993 0.75
182 Recent observations on the diagnosis and pathologic anatomy of posterior fossa meningiomas. Johns Hopkins Med J 1968 0.75
183 Stability of albuterol in continuous nebulization. Int J Pharm Compd 2013 0.75
184 Stability of ranitidine hydrochloride and human insulin in 0.9% sodium chloride injection. Am J Health Syst Pharm 1997 0.75
185 GM food singled out for labeling in the US. Nat Biotechnol 2000 0.75
186 Blood products part of FDA xenotransplant plan. Nat Biotechnol 2000 0.75
187 de Broglie waves in amoeboid motility. Physiol Chem Phys 1976 0.75
188 A new thrust in plant genetics. Science 1984 0.75
189 US Presidential transition prompts biotech policy frenzy. Nat Biotechnol 2001 0.75
190 Tentorial section for decompression of the brain stem and a large basilar aneurysm. Case report. J Neurosurg 1968 0.75
191 Percutaneous trigeminal tractotomy for facial pain. Acta Neurochir (Wien) 1973 0.75
192 Withdrawn Greenpeace Bt suit enters spin cycle. Nat Biotechnol 2000 0.75
193 Stereotaxic surgery using a television guidance system. II. Percutaneous cordotomy. Acta Neurochir (Wien) 1969 0.75
194 NIMH study finds one in five have disorders. Science 1984 0.75
195 Fluorescence in situ hybridization: powerful molecular tool for cancer prognosis. Clin Chem 1995 0.75
196 Analyzing the science and ethics of xenografts. Biotechnology (N Y) 1995 0.75
197 Method for detecting intracranial arteriovenous malformation with an ultrasonic transducer using the Doppler phenomenon. J Neurosurg 1967 0.75
198 NIH and Hughes Institute Form Training Partnership. Science 1984 0.75
199 Physical model evaluation of topical prodrug delivery--simultaneous transport and bioconversion of vidarabine-5'-valerate V: Mechanistic analysis of influence of nonhomogeneous enzyme distributions in hairless mouse skin. J Pharm Sci 1980 0.75
200 Effect of sodium bicarbonate amount on in vitro indomethacin release from self-setting carbonated-apatite cement. Pharm Res 1997 0.75
201 Investigation of gene therapy begins. Nat Biotechnol 2000 0.75
202 Percutaneous trigeminal tractotomy. Variations in delineation of the obex using emulsified Pantopaque. Confin Neurol 1974 0.75
203 US biotech policy issues remain in limbo. Nat Biotechnol 2001 0.75
204 Congress Relents, Boosts USDA Competitive Grants. Science 1984 0.75
205 New US committee considers xenotransplants. Nat Biotechnol 2001 0.75
206 FBI forensics tries mtDNA. Nat Biotechnol 1996 0.75
207 FDA rapidly approves HIV protease inhibitors for children. Nat Biotechnol 1997 0.75
208 U.s. Exchange with poland. Science 1984 0.75
209 Polish Science Struggles On:Continuing exchanges between the United States and Poland are used ingeniously to help beleagured Polish scientists. Science 1984 0.75
210 Use of laser radiation. Surg Neurol 1978 0.75
211 Republican Congress could unsettle U.S. biotech. Biotechnology (N Y) 1995 0.75
212 Overview of FY 2001 federal budget request. Nat Biotechnol 2000 0.75
213 Hydroxyapatite cement based drug delivery systems: drug release in vitro. J Formos Med Assoc 1991 0.75
214 Adverse drug events and the Freedom of Information Act: an apple in Eden. Ann Pharmacother 1992 0.75
215 Congress gives blessing to New York primate lab. Science 1984 0.75
216 EPA re-evaluates StarLink license. Nat Biotechnol 2001 0.75
217 Scientist sues over genetically impure mice. Science 1983 0.75
218 Intractable facial pain relieved by percutaneous trigeminal tractotomy. JAMA 1971 0.75
219 Parasympathectomy: a surgical treatment for uncontrolled salivation. Surg Neurol 1973 0.75
220 Biogen cuts 13 percent including scientists. Science 1984 0.75
221 Thoracic spinal cord stenosis. J Neurosurg 1988 0.75
222 Cystic necrosis of the spinal cord in compressive cervical myelopathy: demonstration by iopamidol CT-myelography. AJR Am J Roentgenol 1986 0.75
223 A new acid abrasion procedure for studying F profiles in demineralized/remineralized bovine tooth enamel. Caries Res 1983 0.75
224 Compatibility of ondansetron hydrochloride with meperidine hydrochloride for combined administration. Ann Pharmacother 1995 0.75
225 FDA, activists seek judgments in food policy lawsuit. Nat Biotechnol 1999 0.75
226 Giant aneurysms of the cavernous carotid artery. Surg Neurol 1985 0.75
227 Physical model approach in the study of the transport of alkyl amines across a silicone rubber membrane in a two-chamber diffusion cell. J Pharm Sci 1984 0.75
228 Lab animal welfare issue gathers momentum. Science 1984 0.75
229 NIHRAC: disguised retirement or vigorous future? Nat Biotechnol 1997 0.75
230 Massachusetts forbids use of impounded pets in labs. Science 1984 0.75
231 The neuropacemaker--relief for patients with intractable pain. RN 1972 0.75
232 Stability of ondansetron hydrochloride, doxorubicin hydrochloride, and dacarbazine or vincristine sulfate in elastomeric portable infusion devices and polyvinyl chloride bags. Am J Health Syst Pharm 1997 0.75
233 FDA urged to comply with 1997 Reform Act. Nat Biotechnol 1998 0.75
234 US anti-bioterror efforts swiftly expanding. Nat Biotechnol 2001 0.75
235 US expands anti-bioterrorist measures. Nat Biotechnol 2001 0.75
236 Responses of the anterior pituitary of ovariectomized rats to oestradiol-17 beta administration. Acta Endocrinol (Copenh) 1981 0.75
237 Precutaneous stereotaxic cordotomy. II. A guidance technique for the anterior approach. Acta Neurochir (Wien) 1968 0.75
238 Tentative Agent Orange settlement reached. Science 1984 0.75
239 Novel topical fluoride delivery system II: remineralization of human teeth. J Pharm Sci 1981 0.75
240 Stability of ceftazidime sodium and teicoplanin sodium in a peritoneal dialysis solution. Am J Health Syst Pharm 1996 0.75
241 Use of laser in surgery. Panminerva Med 1975 0.75
242 Future tense for in utero gene therapy. Nat Biotechnol 1998 0.75
243 Quantitative study of fluoride transport during subsurface dissolution of dental enamel. J Dent Res 1989 0.75
244 Stability of ondansetron hydrochloride stored in a disposable, elastomeric infusion device at 4 degrees C. Am J Hosp Pharm 1993 0.75
245 Endangered u.s. Plants to be collected, conserved. Science 1984 0.75
246 Metabolic demands of rock climbing in transfemoral amputees. Int J Sports Med 2009 0.75
247 Medical school enrollment still edging downward. Science 1984 0.75
248 Trusting in the future: an agenda for all nurses. Br J Nurs 1994 0.75
249 Stability of ceftazidime (with arginine) in an elastomeric infusion device. Am J Health Syst Pharm 1995 0.75
250 Congress drafts generous biomedical budgets. Science 1984 0.75
251 NIH Seeks Training Grant Increase. Science 1984 0.75
252 Rejuvenating ARS's Showcase. Science 1984 0.75
253 Fight over ag research continues. Science 1984 0.75
254 Two-site model for human dental enamel dissolution in EDTA. J Dent Res 1974 0.75
255 USDA struggles to reform its research. Science 1984 0.75
256 US r&d spending increases for 1998. Nat Biotechnol 1997 0.75
257 Simple equipment for the growth of photosynthetic bacteria. J Appl Bacteriol 1977 0.75
258 A model for transhydrogenase. J Theor Biol 1978 0.75
259 . . . as NIH offers guidelines for stem cell research amid broader debate. Nat Biotechnol 2000 0.75
260 Experts attempt to redefine principles for treating HIV. Nat Biotechnol 1997 0.75
261 Green light for gene therapy in healthy volunteers. Nat Biotechnol 1997 0.75
262 SDS removal from protein by polystyrene beads. Anal Biochem 1978 0.75
263 Stability of ondansetron hydrochloride and cyclophosphamide in injectable solutions. Am J Health Syst Pharm 1995 0.75
264 Experimental relationship of radio-frequency electrical current and lesion size for application to percutaneous cordotomy. J Neurosurg 1970 0.75
265 Is biotechnology research insurable? Science 1984 0.75
266 New York primate lab seeks help from Congress. Science 1984 0.75
267 Stability of cisplatin and ondansetron hydrochloride in admixtures for continuous infusion. Am J Health Syst Pharm 1995 0.75
268 Considerable ferment over antifungal agents. Nat Med 1995 0.75
269 Upright patient positioning. Surg Neurol 1981 0.75
270 USDA asks "can organic foods be recombinant?". Nat Biotechnol 1998 0.75
271 Activists challenge FDA food policy. Nat Biotechnol 1998 0.75
272 Hydrocephalus secondary to hemorrhage from a basilar artery aneurysm. With a note on embolization technique. Acta Neurochir (Wien) 1967 0.75
273 Beyond protease inhibitors. Nat Biotechnol 1996 0.75
274 NSF Studies Cooperative R&D. Science 1984 0.75
275 FDA not yet moved by biotech food critics. Nat Biotechnol 2000 0.75
276 Impure mice draw legal complaint. Science 1983 0.75
277 Ban on shooting animals for research is lifted. Science 1984 0.75
278 Surreal US budget again favors R&D spending. Nat Biotechnol 1996 0.75
279 Interferon patent contest kicks off in europe. Science 1984 0.75
280 Inline filtration of ondansetron hydrochloride during simulated i.v. administration. Am J Hosp Pharm 1993 0.75
281 Neuropacemaker for relief of intractable pain. Med Ann Dist Columbia 1971 0.75
282 A new method of percutaneous chordotomy for relief of intractable pain. Med Ann Dist Columbia 1969 0.75
283 Coupled oscillator theory of enzyme action. Mol Biol Biochem Biophys 1980 0.75
284 The central x-ray beam in stereotaxis. Am J Roentgenol Radium Ther Nucl Med 1970 0.75
285 Gas production of three brands of ceftazidime. Am J Hosp Pharm 1991 0.75
286 Response to radiation. Semin Radiat Oncol 2004 0.75
287 Intracranial air bubbles localizing cerebrospinal fluid fistula. J Comput Assist Tomogr 1979 0.75
288 FDA advisory panel okays HIV vaccine. Biotechnology (N Y) 1995 0.75
289 Chemical ecology group formed. Science 1983 0.75
290 Stability of paclitaxel with ondansetron hydrochloride or ranitidine hydrochloride during simulated Y-site administration. Am J Hosp Pharm 1994 0.75
291 Percutaneous stereotaxic cordotomy. I. Problems encountered. Acta Neurochir (Wien) 1968 0.75
292 Recent advances in neurological surgery. RN 1972 0.75
293 Another genome, another kingdom, another set of surprises. Nat Biotechnol 1996 0.75
294 Retiring frees NIH "guest" to consult. Science 1984 0.75
295 Stem cell hearing stirs bioethics debate. Nat Biotechnol 1999 0.75
296 Application of effect-compartment model to bumetanide-indomethacin interaction in dogs. J Pharmacokinet Biopharm 1983 0.75
297 Microsurgical treatment of neurovascular disease. Part III: neurology, neuroanesthesiology. Neurosurgery 1978 0.75
298 US deliberates on embryonic stem cells, cloning. Nat Biotechnol 2001 0.75
299 Novel topical fluoride delivery system I: remineralization of ground bovine teeth. J Pharm Sci 1981 0.75
300 Physical model evaluation of topical prodrug delivery--simultaneous transport and bioconversion of vidarabine-5'-valerate III: Permeability differences of vidarabine and n-pentanol in components of hairless mouse skin. J Pharm Sci 1980 0.75
301 Ondansetron Suppositories: Extemporaneous Preparation, Drug Release, Stability and Flux through Rabbit Rectal Membrane. Int J Pharm Compd 2013 0.75
302 Delineation of the obex by contrast radiography during percutaneous trigeminal tractotomy. Technical note. J Neurosurg 1972 0.75
303 Technology export law reform facing difficulties. Science 1983 0.75
304 Facing the challenge of combination vaccines. Biotechnology (N Y) 1995 0.75
305 In vivo remineralization using a sustained topical fluoride delivery system. J Dent Res 1980 0.75
306 Geron-Roslin alliance aims broadly at degenerative diseases. Nat Biotechnol 1999 0.75
307 EU--US experts urge stiffer rules for biotech foods. Nat Biotechnol 2001 0.75
308 Bioethicists ruminate separately on clones, gene 'enhancements'. Nat Biotechnol 1997 0.75
309 US, EU prepare for further biotech food dispute. Nat Biotechnol 2001 0.75
310 Glomus jugulare tumor. Nebr Med J 1988 0.75
311 Quantitation of cutaneous Langerhans' cells of sarcoidosis patients. Ann N Y Acad Sci 1986 0.75
312 US agbio controversies continue. Nat Biotechnol 1999 0.75
313 Stability of ondansetron hydrochloride in injectable solutions at -20, 5, and 25 degrees C. Am J Hosp Pharm 1992 0.75
314 Pharmacoeconomics: drug pricing's new guise. Biotechnology (N Y) 1995 0.75
315 Skin metastases from small-cell carcinoma of the lung. J Dermatol Surg Oncol 1983 0.75
316 Supreme court to review pesticide data release. Science 1983 0.75
317 Direct membrane method for the study of interface-controlled transport of cholesterol in aqueous media. J Pharm Sci 1985 0.75
318 Intracranial nail-sets. An unusual self-inflicted foreign body. Case report. Acta Neurochir (Wien) 1971 0.75
319 Oestradiol release from self-setting apatitic bone cement responsive to plasma-calcium level in ovariectomized rats, and its physicochemical mechanism. J Pharm Pharmacol 1997 0.75
320 Microsurgical treatment of neurovascular disease. Part I. Personnel, equipment, extracranial-intracranial anastomosis. Neurosurgery 1978 0.75
321 The status of stereotaxic surgery for movement disorders and intractable pain. Med Ann Dist Columbia 1966 0.75
322 U.s.-Poland exchanges remain uncertain. Science 1984 0.75
323 Use of laser in surgery. Panminerva Med 1975 0.75
324 Redundant nerve roots in the cauda equina. Case report. J Neurosurg 1969 0.75
325 The experimental effect of direct electrical current on intracranial arteries and the blood-brain barrier. J Neurosurg 1974 0.75
326 Calculation of intercrystalline solution composition during in vitro subsurface lesion formation in dental minerals. J Pharm Sci 1996 0.75
327 Animal rights bill defeated in California. Science 1984 0.75
328 Insulin patent dispute revisits old biotechnology battleground. Nat Biotechnol 1997 0.75
329 Mystery plea for review of seed and biotech mergers. Nat Biotechnol 1998 0.75
330 NIMH faces renewed uncertainties. Science 1984 0.75
331 Effect of a dual-lumen peripheral catheter on the delivery of known incompatible medications. Ann Pharmacother 1998 0.75
332 Variations in delineation of the obex by contrast radiography during percutaneous trigeminal tractotomy. Neuroradiology 1973 0.75
333 FDA panel reluctantly approves AIDS vaccine trial. Nat Med 1995 0.75
334 Purity of rats also questioned. Science 1983 0.75
335 Sweeping bioethical reform proposals contemplated for trials. Nat Biotechnol 2000 0.75
336 Letters to the editor. Science 1975 0.75
337 Guidelines for artificial heart implants revised. Science 1984 0.75
338 EPA issues, USDA amends respective biotech rules. Nat Biotechnol 1997 0.75
339 AIDS product development follows its own rules. Biotechnology (N Y) 1994 0.75
340 Effect of plasma-calcium-level-responsive oestradiol release from apatitic bone cement on bone mineral density in ovariectomized rats. J Pharm Pharmacol 1999 0.75
341 Fake biotech drugs raise concerns. Nat Biotechnol 2001 0.75
342 Compatibility and stability of ondansetron hydrochloride with morphine sulfate and with hydromorphone hydrochloride in 0.9% sodium chloride injection at 4, 22, and 32 degrees C. Am J Hosp Pharm 1994 0.75
343 Concepts of intracranial pressure and the blood-brain barrier. Clin Proc Child Hosp Dist Columbia 1966 0.75
344 Microsurgical treatment of vascular disease. Part II. Intracranial aneurysms, intracranial and intraspinal arteriovenous malformations. Neurosurgery 1978 0.75
345 Review of NIHRAC focuses on gene therapy. Biotechnology (N Y) 1995 0.75
346 Double standards in GMP deduplication row. Nat Biotechnol 1996 0.75
347 House and senate prepare for battle on ag research. Science 1984 0.75
348 Agent orange: guarded reassurance. Science 1984 0.75
349 FDA financial disclosure plan flops. Biotechnology (N Y) 1995 0.75
350 Intracranial vasospasm: a study with iron compounds. Surg Neurol 1979 0.75
351 Solid-phase sequencing on the gas-phase sequencer. Anal Biochem 1986 0.75
352 Stability of ranitidine hydrochloride during simulated home care use. Am J Hosp Pharm 1994 0.75
353 Changes in animal care policy proposed. Science 1984 0.75
354 Microbial genomics: Milestones mount exponentially. Nat Biotechnol 1997 0.75
355 Syrinx of the conus medullaris and filum terminale in association with multiple hemangioblastomas. Surg Neurol 1985 0.75
356 Candicidin therapy in mixed mycotic-allergic skin lesions. Curr Ther Res Clin Exp 1966 0.75
357 Agricultural study sees big changes after 2000. Science 1983 0.75
358 Towards understanding human genetic diseases. Biotechnology (N Y) 1990 0.75
359 . . . but new plans for surveillance are still being proposed. Nat Med 1996 0.75
360 Lab break-in stirs animal welfare debate. Science 1984 0.75
361 Zeolites Catalyze Patent Dispute: Patent infringement suits involving corporate giants could hinge on esoteric points of analytic data; much is at stake. Science 1985 0.75
362 Recent advances in intracranial aneurysm surgery. W V Med J 1976 0.75
363 Biotech food labeling: polite hedging or loggerheads? Nat Biotechnol 1997 0.75
364 Two more HIV protease inhibitors approved. Nat Biotechnol 1996 0.75
365 Hercules and Kairos catalyze enzyme deal. Nat Biotechnol 1999 0.75
366 Stability of ondansetron hydrochloride in syrups compounded from tablets. Am J Hosp Pharm 1994 0.75
367 DNA-based testing not yet ready for routine screening of blood. Nat Med 1995 0.75
368 EPA ban on bromoxynil undercuts Calgene's transgenic cotton. Nat Biotechnol 1998 0.75
369 US bioethicists say continue human cloning moratorium. Nat Biotechnol 1997 0.75
370 A new method of stereotaxis. Radiology 1969 0.75
371 Stereotaxic surgery using a television guidance system. I. Thalamotomy. Acta Neurochir (Wien) 1969 0.75
372 Redox enzyme models from polymerized aminoacyladenylates. Experientia 1972 0.75
373 US plans to protect clinical research participants. Nat Biotechnol 2000 0.75
374 Topical vaginal drug delivery I: effect of the estrous cycle on vaginal membrane permeability and diffusivity of vidarabine in mice. J Pharm Sci 1983 0.75
375 T6-antigen-bearing cells in eosinophilic granuloma of bone. JAMA 1983 0.75
376 Control of common carotid and innominate artery hemorrhage complicating tracheostomy. J Neurosurg 1973 0.75
377 The role of the hydroxyl ion during vasodilation of arteries caused by DC negative electrical current. Surg Neurol 1974 0.75
378 The evolution of protein sequences by repetitious gene duplication: clostridial flavodoxin. J Mol Evol 1978 0.75
379 Alzheimer's disease: plans but no new funds. Science 1984 0.75
380 Kessler's departure from FDA gets mixed response. Nat Biotechnol 1997 0.75
381 Surgical treatment of brain stem carcinoma: case report. Neurosurgery 1980 0.75
382 DuPont Stakes Out Turf for Life Sciences Research. Science 1984 0.75
383 GAO report documents rising indirect costs. Science 1984 0.75
384 FDA withholds xeno data. Nat Biotechnol 2001 0.75
385 Debate on Learning Theory Is Shifting: Though many psychologists and ethologists now agree on using a mechanistic approach, some linguists doubt its adequacy. Science 1983 0.75
386 International group suspends Nestlé boycott. Science 1984 0.75
387 Effect of laser irradiation on the dissolution kinetics of hydroxyapatite preparations. J Pharm Sci 1990 0.75
388 Influence of 1-dodecylazacycloheptan-2-one (Azone) on the topical therapy of cutaneous herpes simplex virus type 1 infection in hairless mice with 2',3'-di-O-acetyl-9-beta-D-arabinofuranosyladenine and 5'-O-valeryl-9-beta-D-arabinofuranosyladenine. J Pharm Sci 1985 0.75
389 The ethical roar of germ-line gene therapy. Biotechnology (N Y) 1995 0.75
390 The quaternary structure of a unique phycobiliprotein: B-phycoerythrin from Porphyridium cruentum. Biochem Biophys Res Commun 1977 0.75
391 Summer recess might squeeze FDA reform bill. Nat Biotechnol 1997 0.75
392 Automatic cycling bipolar coagulator. Surg Neurol 1977 0.75
393 Mary Lasker enshrined eponymously at NIH. Science 1984 0.75
394 Stability of ondansetron hydrochloride injection in extemporaneously prepared oral solutions. Am J Hosp Pharm 1993 0.75
395 Monsanto unaffected by merger halt? Nat Biotechnol 1998 0.75
396 Troubles plague polish physicists. Science 1985 0.75
397 Cerebral midline displacement with a cerebellar lesion. Acta Neurol Latinoam 1965 0.75
398 Polar coordinates and television monitoring in stereotaxic brain surgery. Confin Neurol 1969 0.75
399 Recent advances in neurological surgery. Med Ann Dist Columbia 1971 0.75
400 The neuropacemaker--relief for patients with intractable pain. RN 1972 0.75
401 AIDS researchers emphasize new drug combinations. Nat Biotechnol 1997 0.75
402 Despite size difference, Monsanto, AHP to merge. Nat Biotechnol 1998 0.75
403 NIH rejects modified plan to clone shiga toxin. Science 1984 0.75
404 Nestle Complying with WHO Code for Infant Formulas. Science 1983 0.75
405 Delegates face many challenges negotiating Biosafety Protocol. Nat Biotechnol 1999 0.75
406 Self-consistent field calculations of isoalloxazine. Biochim Biophys Acta 1965 0.75
407 HIV vector challenges gene therapy oversight. Nat Biotechnol 1997 0.75
408 Perforation of the anterior annulus during lumbar discectomy. Case report. J Neurosurg 1973 0.75
409 Researchers wary of fear-based ban on lentivirus gene therapy. Nat Biotechnol 1998 0.75
410 Scrutiny of gene therapy broadens, intensifies. Nat Biotechnol 2000 0.75
411 Patents Encroaching on Research Freedom: A tradition of disregarding patent infringement when it involves experimental use of an invention may be eroding for biologists. Science 1984 0.75
412 Anaerobic stopped flow apparatus. Rev Sci Instrum 1966 0.75
413 Electrical resistance in percutaneous cordotomy. Technical note. Acta Neurochir (Wien) 1969 0.75
414 Fluorescein angiography in microvascular surgery: a study using the rodent artery. Stroke 1974 0.75
415 Gene splicers square off in patent courts. Science 1984 0.75
416 Stability of ranitidine hydrochloride with ondansetron hydrochloride or fluconazole during simulated Y-site administration. Am J Hosp Pharm 1994 0.75
417 Charles river responds to lawsuit on impure mice. Science 1983 0.75
418 The effect of DC electrical current on the rodent artery. Surg Neurol 1974 0.75
419 Memories are made of this. Science 1983 0.75
420 The low incidence of cerebral aneurysms in the Middle East: is it a myth? Neurosurgery 1988 0.75
421 Dioxin trial pits workers against monsanto. Science 1984 0.75
422 Evaluation of computer-assisted self-instructional module for pharmacy continuing education. Hosp Pharm 1982 0.75
423 Politics could hamper FDA reform. Biotechnology (N Y) 1995 0.75
424 Europe and FDA agree to limited inspections. Nat Biotechnol 1997 0.75
425 Intracranial Hodgkin's disease simulating pterional meningioma: report of a case. Med Ann Dist Columbia 1969 0.75
426 Vascular clips for the microsurgical treatment of stroke. Stroke 1976 0.75
427 The brain's dynamic way of keeping in touch. Science 1984 0.75
428 Researcher's suit against NCI wins mixed judgment. Science 1984 0.75
429 FDA seeks "comfort factors" before removing hold on porcine xenotransplantation trials. Nat Biotechnol 1998 0.75
430 Stability of ondansetron hydrochloride and five antineoplastic medications. Am J Health Syst Pharm 1996 0.75
431 Stereotaxic brain surgery. II. Description of a method using biplane television guidance. Acta Neurochir (Wien) 1968 0.75
432 Bill proposes added review of animal research. Science 1984 0.75
433 Effects of procainamide and chloramphenicol on acute vasospasm. Surg Neurol 1977 0.75
434 An unusual acoustic neurinoma localized between brain stem and basilar artery using emulsified pantopaque cisternography. Surg Neurol 1974 0.75
435 Atracurium decay and the formation of laudanosine in humans. Anesthesiology 1991 0.75
436 For AIDS, the FDA may be reforming itself. Biotechnology (N Y) 1995 0.75
437 Multiple giant aneurysms. Surg Neurol 1979 0.75
438 U.s.--poland exchanges slow to resume. Science 1984 0.75
439 Stability of ondansetron hydrochloride in portable infusion-pump reservoirs. Am J Hosp Pharm 1992 0.75
440 Adjusting FDA policies to address bioterrorist threat. Nat Biotechnol 1999 0.75
441 Stability of ondansetron hydrochloride injection in various beverages. Am J Health Syst Pharm 1995 0.75
442 Shiga toxin: no smoking gun. Science 1984 0.75
443 Fusion Technique causes Fission. Science 1984 0.75
444 Investors, HMOs, policy makers see value in vaccines. Nat Biotechnol 1996 0.75
445 The empty sella: air-enhanced CT. Radiology 1985 0.75